The primary blood test used to screen for lupus is called the ANA test, short for antinuclear antibody test. It detects antibodies that mistakenly attack the nuclei of your own cells instead of targeting invaders like bacteria or viruses. A positive ANA result doesn’t confirm lupus on its own, though. Diagnosing lupus typically requires a combination of blood tests, symptoms, and clinical evaluation.
How the ANA Test Works
Your immune system produces antibodies to fight infections. In autoimmune conditions like lupus, some of those antibodies go rogue and target healthy tissue. The ANA test checks whether your blood contains antibodies directed at cell nuclei, the control centers that coordinate essential cell functions.
Results are reported as a titer, which reflects how many times a blood sample can be diluted before the antibodies are no longer detectable. Common titers include 1:40, 1:80, 1:160, and 1:320. Higher titers are more likely to signal a real autoimmune condition. In one study of patients with confirmed autoimmune diseases, the median titer was 1:320. A titer of 1:40, on the other hand, shows up in roughly 30% of healthy people with no autoimmune disease at all.
This is the key limitation of the ANA test: it’s sensitive but not specific. Most people with lupus will test positive, which makes it a good screening tool. But a positive result can also appear in people with other autoimmune conditions, certain infections, or no disease whatsoever. A negative ANA makes lupus much less likely, which is really the test’s greatest strength.
Confirmatory Antibody Tests
When an ANA test comes back positive and lupus is suspected, more targeted blood tests help narrow the diagnosis. Two are particularly important:
- Anti-dsDNA antibodies target double-stranded DNA and are highly specific to lupus. At 99% specificity, meaning almost no false positives, this test picks up about 30% of lupus cases. When it’s positive, it’s a strong indicator.
- Anti-Smith (anti-Sm) antibodies are even more specific to lupus and rarely appear in other conditions. They have a similar tradeoff: at 99% specificity, the sensitivity is about 26%, so a negative result doesn’t rule lupus out, but a positive one carries significant diagnostic weight.
These tests work as follow-ups, not standalone screens. Their value lies in confirmation. If your doctor orders an “extractable nuclear antigen” panel or an “ENA panel,” these antibodies are typically included.
Antiphospholipid Antibodies and Clot Risk
About a third of people with lupus carry antiphospholipid antibodies, which increase the risk of blood clots, stroke, and pregnancy complications. Three are routinely tested:
- Lupus anticoagulant (LA)
- Anticardiolipin antibody (aCL)
- Anti-beta-2 glycoprotein 1 (anti-β2 GPI)
Despite its name, lupus anticoagulant doesn’t actually thin the blood. It promotes clotting. These tests matter because they change how lupus is managed. If you test positive, your treatment plan may include blood-thinning medication to reduce clot risk.
Complement Levels: C3 and C4
Complement proteins are part of the immune system’s toolkit for clearing infections and damaged cells. In active lupus, the immune system burns through complement proteins faster than the body can replace them, so blood levels drop. Two complement proteins are routinely measured: C3 and C4.
Low C3 is typically defined as below 83 mg/dL, and low C4 as below 10 mg/dL. Decreased levels of both are commonly seen in patients with kidney involvement or blood-related complications of lupus. Patients whose complement levels fluctuate over time tend to have higher rates of kidney damage. Because of this, complement levels are useful not just for diagnosis but for tracking disease activity over months and years.
Inflammation Markers: ESR and CRP
Two general inflammation tests often appear on a lupus blood panel: erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Neither is specific to lupus. Both rise with inflammation from almost any cause. Their real value lies in what they reveal together.
ESR tends to climb during lupus flares, but it also rises with infections, making it unreliable on its own. CRP behaves differently in lupus than in most other inflammatory conditions. Lupus patients produce high levels of a signaling molecule called interferon-alpha, which actually suppresses CRP production. So during a typical lupus flare, CRP often stays relatively low.
This quirk becomes clinically useful. When a lupus patient develops a fever, comparing ESR and CRP can help distinguish a flare from an infection. Research from the Cleveland Clinic found that CRP values above 6.0 mg/dL in lupus patients were associated with infection rather than a flare. The ratio of ESR to CRP also matters: ratios of 15 or higher pointed toward a lupus flare, while ratios of 2 or lower pointed toward infection.
What a Full Lupus Panel Looks Like
There is no single “lupus test.” Diagnosis involves assembling evidence from multiple blood tests alongside symptoms like joint pain, skin rashes, fatigue, and organ involvement. A typical workup includes the ANA as a starting point, followed by anti-dsDNA and anti-Smith antibodies for confirmation, complement levels to assess organ risk, antiphospholipid antibodies to evaluate clotting risk, and ESR and CRP to gauge inflammation.
A complete blood count and kidney function tests (urinalysis, creatinine) are also standard, since lupus frequently affects blood cells and the kidneys. The combination of all these results, not any single number, is what builds or rules out a lupus diagnosis. If your ANA comes back positive but you feel fine and have no other abnormal results, lupus is unlikely. The ANA opens the door to further investigation, but it doesn’t walk through it alone.